Table 1.

Neither the amplitude nor the decay phase of the spontaneous postsynaptic currents (sPSCs) showed significant change after the various treatments.

	Amplitude (control; pA)	Amplitude change (% of the control)	Decay tau (control; ms)	Decay tau change (% of the control)
E2	−37.0 ± 5.0	104.7 ± 3.6	14.9 ± 1.9	129.9 ± 12.4
Faslodex+E2	−33.7 ± 3.9	99.3 ± 4.3	25.4 ± 5.6	148.5 ± 29.5
AM251+E2	−37.4 ± 6.8	112.6 ± 14.1	23.6 ± 4.1	153.9 ± 33.1
THL+E2	−36.3 ± 4.1	101.1 ± 3.6	16.2 ± 1.4	130.3 ± 17.2

The table shows the mean amplitude and decay tau parameters before drug administration and the percentage change in mean amplitudes and decay tau resulting from the drug application.